AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.890
+0.160 (5.86%)
At close: Nov 4, 2024, 4:00 PM
2.740
-0.150 (-5.19%)
Pre-market: Nov 5, 2024, 9:14 AM EST
AbCellera Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 852 | 1,657 | 2,898 | 4,027 | 10,832 | - | |
| Market Cap Growth | -42.44% | -42.83% | -28.02% | -62.83% | - | - | |
| Enterprise Value | 275 | 952 | 2,106 | 3,305 | 10,829 | - | |
| Last Close Price | 2.89 | 5.71 | 10.13 | 14.30 | 40.24 | - | |
| PE Ratio | - | -11.20 | 20.26 | 29.79 | 89.04 | - | |
| PS Ratio | 25.69 | 43.57 | 5.97 | 10.73 | 46.46 | - | |
| PB Ratio | 0.79 | 1.44 | 2.35 | 3.93 | 13.04 | - | |
| P/FCF Ratio | -3.88 | -13.71 | 14.02 | 21.63 | 832.15 | - | |
| P/OCF Ratio | -6.38 | -37.76 | 10.45 | 16.46 | 477.40 | - | |
| EV/Sales Ratio | 8.33 | 25.03 | 4.34 | 8.81 | 46.45 | - | |
| EV/EBITDA Ratio | -0.76 | -4.47 | 8.62 | 15.10 | 67.32 | - | |
| EV/EBIT Ratio | -0.54 | -4.01 | 9.36 | 16.17 | 69.40 | - | |
| EV/FCF Ratio | -0.85 | -7.88 | 10.19 | 17.76 | 831.92 | - | |
| Debt / Equity Ratio | 0.06 | 0.07 | 0.07 | 0.04 | 0.01 | 0.67 | |
| Debt / EBITDA Ratio | - | - | 0.32 | 0.18 | 0.03 | - | |
| Debt / FCF Ratio | -0.34 | -0.64 | 0.40 | 0.22 | 0.34 | -5.29 | |
| Asset Turnover | 0.02 | 0.03 | 0.34 | 0.32 | 0.45 | 0.52 | |
| Inventory Turnover | - | 133.12 | 108.81 | 69.86 | 71.97 | - | |
| Quick Ratio | 8.48 | 6.93 | 8.37 | 7.44 | 7.81 | 1.51 | |
| Current Ratio | 9.34 | 7.33 | 8.67 | 7.70 | 7.86 | 1.60 | |
| Return on Equity (ROE) | -15.55% | -12.27% | 14.03% | 16.53% | 28.29% | -20.23% | |
| Return on Assets (ROA) | -13.26% | -9.79% | 9.83% | 10.99% | 18.95% | -11.44% | |
| Return on Capital (ROIC) | -15.99% | -11.65% | 11.81% | 13.44% | 22.89% | -15.98% | |
| Earnings Yield | -20.64% | -8.84% | 5.47% | 3.81% | 1.10% | - | |
| FCF Yield | -23.18% | -7.29% | 7.13% | 4.62% | 0.12% | - | |
| Buyback Yield / Dilution | -1.70% | 8.15% | 1.09% | -20.96% | -73.88% | 11.68% | |
| Total Shareholder Return | -1.70% | 8.15% | 1.09% | -20.96% | -73.88% | 11.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.